{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:22Z","timestamp":1792783942312,"version":"4.5.0"},"reference-count":134,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Marie Sk\u0142odowska-Curie Actions Individual Fellowship","award":["659615"],"award-info":[{"award-number":["659615"]}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.csbj.2015.11.001","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T20:16:32Z","timestamp":1448568992000},"page":"58-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":356,"title":["Self-assembling protein nanoparticles in the design of vaccines"],"prefix":"10.34133","volume":"14","author":[{"given":"Jacinto","family":"L\u00f3pez-Sagaseta","sequence":"first","affiliation":[{"name":"GlaxoSmithKline Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Malito","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Bottomley","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth J.","year":"2003","unstructured":"Ehreth J.: The global value of vaccination. Vaccine 2003; 21: 596.","journal-title":"Vaccine"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402981111"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/14787210.2015.983902","article-title":"Treatment of drug-resistant Shigella infections","volume":"13","author":"Klontz K.C.","year":"2015","unstructured":"Klontz K.C. and Singh N.: Treatment of drug-resistant Shigella infections. Expert Rev Anti Infect Ther 2015; 13: 69.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400472111"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/169419a0","article-title":"An abnormal protein associated with tobacco mosaic virus infection","volume":"169","author":"Takahashi W.N.","year":"1952","unstructured":"Takahashi W.N. and Ishii M.: An abnormal protein associated with tobacco mosaic virus infection. Nature 1952; 169: 419.","journal-title":"Nature"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.7.5.569-576.1971"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00434-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2868"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nano.2006.07.009","article-title":"Adaptations of nanoscale viruses and other protein cages for medical applications","volume":"2","author":"Lee L.A.","year":"2006","unstructured":"Lee L.A. and Wang Q.: Adaptations of nanoscale viruses and other protein cages for medical applications. Nanomedicine 2006; 2: 137.","journal-title":"Nanomedicine"},{"key":"e_1_3_2_11_2","first-page":"269","article-title":"Influenza virus-like particles as pandemic vaccines","volume":"333","author":"Kang S.M.","year":"2009","unstructured":"Kang S.M., Pushko P., Bright R.A., Smith G. and Compans R.W.: Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009; 333: 269.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi M.O.","year":"2010","unstructured":"Oyewumi M.O., Kumar A. and Cui Z.: Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 2010; 9: 1095.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-94-007-6552-8_2","article-title":"The basic architecture of viruses","volume":"68","author":"Caston J.R.","year":"2013","unstructured":"Caston J.R. and Carrascosa J.L.: The basic architecture of viruses. Subcell Biochem 2013; 68: 53.","journal-title":"Subcell Biochem"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.29.1.105"},{"key":"e_1_3_2_15_2","first-page":"22","article-title":"There's plenty of room at the bottom","author":"Feynman R.P.","year":"1960","unstructured":"Feynman R.P.: There's plenty of room at the bottom. Eng Sci 1960; : 22.","journal-title":"Eng Sci"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2004.06.006"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.9.5275"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2013.06.002"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68927-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/j.1460-2075.1992.tb05156.x","article-title":"Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles","volume":"11","author":"Burns N.R.","year":"1992","unstructured":"Burns N.R., Saibil H.R., White N.S., Pardon J.F., Timmins P.A., Richardson S.M. et al: Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles. EMBO J 1992; 11: 1155.","journal-title":"EMBO J"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke B.E.","year":"1987","unstructured":"Clarke B.E., Newton S.E., Carroll A.R., Francis M.J., Appleyard G., Syred A.D. et al: Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 1987; 330: 381.","journal-title":"Nature"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2425433"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0042-6822(92)90922-C","article-title":"Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles","volume":"190","author":"Belyaev A.S.","year":"1992","unstructured":"Belyaev A.S. and Roy P.: Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles. Virology 1992; 190: 840.","journal-title":"Virology"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/viro.1994.1059","article-title":"Chimeric parvovirus B19 capsids for the presentation of foreign epitopes","volume":"198","author":"Brown C.S.","year":"1994","unstructured":"Brown C.S., Welling-Wester S., Feijlbrief M., Van Lent J.W. and Spaan W.J.: Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology 1994; 198: 477.","journal-title":"Virology"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.91.19.9067","article-title":"Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli","volume":"91","author":"Hwang D.J.","year":"1994","unstructured":"Hwang D.J., Roberts I.M. and Wilson T.M.: Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli. Proc Natl Acad Sci U S A 1994; 91: 9067.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/j.1460-2075.1991.tb07772.x","article-title":"Three-dimensional structure of a mouse-adapted type 2\/type 1 poliovirus chimera","volume":"10","author":"Yeates T.O.","year":"1991","unstructured":"Yeates T.O., Jacobson D.H., Martin A., Wychowski C., Girard M., Filman D.J. et al: Three-dimensional structure of a mouse-adapted type 2\/type 1 poliovirus chimera. EMBO J 1991; 10: 2331.","journal-title":"EMBO J"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1073\/pnas.89.1.207","article-title":"Infectious enveloped RNA virus antigenic chimeras","volume":"89","author":"London S.D.","year":"1992","unstructured":"London S.D., Schmaljohn A.L., Dalrymple J.M. and Rice C.M.: Infectious enveloped RNA virus antigenic chimeras. Proc Natl Acad Sci U S A 1992; 89: 207.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland S.M.","year":"2007","unstructured":"Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S. et al: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60946-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160613106"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2893"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00109"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.copbio.2015.03.014","article-title":"Nanoparticles as synthetic vaccines","volume":"34","author":"Smith J.D.","year":"2015","unstructured":"Smith J.D., Morton L.D. and Ulery B.D.: Nanoparticles as synthetic vaccines. Curr Opin Biotechnol 2015; 34: 217.","journal-title":"Curr Opin Biotechnol"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.5.797"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/erv.12.153","article-title":"Insect cells as a production platform of complex virus-like particles","volume":"12","author":"Fernandes F.","year":"2013","unstructured":"Fernandes F., Teixeira A.P., Carinhas N., Carrondo M.J. and Alves P.M.: Insect cells as a production platform of complex virus-like particles. Expert Rev Vaccines 2013; 12: 225.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201400387"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6272395"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/298347a0"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer W.J.","year":"1984","unstructured":"McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J. and Hilleman M.R.: Human hepatitis B vaccine from recombinant yeast. Nature 1984; 307: 178.","journal-title":"Nature"},{"key":"e_1_3_2_40_2","first-page":"1021","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating G.M.","year":"2003","unstructured":"Keating G.M. and Noble S.: Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63: 1021.","journal-title":"Drugs"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines","volume":"116","author":"Lowy D.R.","year":"2006","unstructured":"Lowy D.R. and Schiller J.T.: Prophylactic human papillomavirus vaccines. J Clin Invest 2006; 116: 1167.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90071-1"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4646"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer R.","year":"1992","unstructured":"Kirnbauer R., Booy F., Cheng N., Lowy D.R. and Schiller J.T.: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992; 89: 12180.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/jvi.67.4.1936-1944.1993","article-title":"Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles","volume":"67","author":"Rose R.C.","year":"1993","unstructured":"Rose R.C., Bonnez W., Reichman R.C. and Garcea R.L.: Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 1993; 67: 1936.","journal-title":"J Virol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"31803","DOI":"10.1074\/jbc.M706380200","article-title":"Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies","volume":"282","author":"Bishop B.","year":"2007","unstructured":"Bishop B., Dasgupta J., Klein M., Garcea R.L., Christensen N.D., Zhao R. et al: Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J Biol Chem 2007; 282: 31803.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"e01104","DOI":"10.1128\/mBio.01104-14","article-title":"Maturation of the human papillomavirus 16 capsid","volume":"5","author":"Cardone G.","year":"2014","unstructured":"Cardone G., Moyer A.L., Cheng N., Thompson C.D., Dvoretzky I., Lowy D.R. et al: Maturation of the human papillomavirus 16 capsid. MBio 2014; 5: e01104.","journal-title":"MBio"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.virol.2015.04.016","article-title":"Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization","volume":"483","author":"Guan J.","year":"2015","unstructured":"Guan J., Bywaters S.M., Brendle S.A., Lee H., Ashley R.E., Makhov A.M. et al: Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization. Virology 2015; 483: 253.","journal-title":"Virology"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JVI.02898-14","article-title":"A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment","volume":"89","author":"Lee H.","year":"2015","unstructured":"Lee H., Brendle S.A., Bywaters S.M., Guan J., Ashley R.E., Yoder J.D. et al: A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment. J Virol 2015; 89: 1428.","journal-title":"J Virol"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/cncr.23704","article-title":"Human papillomavirus infection and the primary and secondary prevention of cervical cancer","volume":"113","author":"Lowy D.R.","year":"2008","unstructured":"Lowy D.R., Solomon D., Hildesheim A., Schiller J.T. and Schiffman M.: Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008; 113: 1980.","journal-title":"Cancer"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1128\/jvi.65.12.6994-6997.1991","article-title":"Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins","volume":"65","author":"Sabara M.","year":"1991","unstructured":"Sabara M., Parker M., Aha P., Cosco C., Gibbons E., Parsons S. et al: Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins. J Virol 1991; 65: 6994.","journal-title":"J Virol"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1099\/0022-1317-70-6-1453","article-title":"Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector","volume":"70","author":"Urakawa T.","year":"1989","unstructured":"Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W. et al: Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol 1989; 70: 1453.","journal-title":"J Gen Virol"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/jvi.68.4.2442-2457.1994","article-title":"Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins","volume":"68","author":"Thomsen D.R.","year":"1994","unstructured":"Thomsen D.R., Roof L.L. and Homa F.L.: Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol 1994; 68: 2442.","journal-title":"J Virol"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.1999.0843"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/296677a0","article-title":"Electron microscopy of hepatitis B core antigen synthesized in E. coli","volume":"296","author":"Cohen B.J.","year":"1982","unstructured":"Cohen B.J. and Richmond J.E.: Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature 1982; 296: 677.","journal-title":"Nature"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/386088a0","article-title":"Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy","volume":"386","author":"Bottcher B.","year":"1997","unstructured":"Bottcher B., Wynne S.A. and Crowther R.A.: Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997; 386: 88.","journal-title":"Nature"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90142-2"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1073\/pnas.87.7.2545","article-title":"Immunological properties of hepatitis B core antigen fusion proteins","volume":"87","author":"Francis M.J.","year":"1990","unstructured":"Francis M.J., Hastings G.Z., Brown A.L., Grace K.G., Rowlands D.J., Brown F. et al: Immunological properties of hepatitis B core antigen fusion proteins. Proc Natl Acad Sci U S A 1990; 87: 2545.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1656(95)00118-2"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6519-6527.2004"},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen J.","year":"2010","unstructured":"Cohen J., Nussenzweig V., Nussenzweig R., Vekemans J. and Leach A.: From the circumsporozoite protein to the RTS, S\/AS candidate vaccine. Hum Vaccin 2010; 6: 90.","journal-title":"Hum Vaccin"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS, S\/AS01 malaria vaccine in African infants","volume":"367","author":"Rts S.C.T.P.","year":"2012","unstructured":"Rts S.C.T.P., Agnandji S.T., Lell B., Fernandes J.F., Abossolo B.P., Methogo B.G. et al: A phase 3 trial of RTS, S\/AS01 malaria vaccine in African infants. N Engl J Med 2012; 367: 2284.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1AQ634"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.11.1775"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4161\/hv.6.11.12655","article-title":"Virus-like particle based vaccines for Alzheimer disease","volume":"6","author":"Chackerian B.","year":"2010","unstructured":"Chackerian B.: Virus-like particle based vaccines for Alzheimer disease. Hum Vaccin 2010; 6: 926.","journal-title":"Hum Vaccin"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.10.22"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12966"},{"key":"e_1_3_2_70_2","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner A.","year":"2002","unstructured":"Jegerlehner A., Tissot A., Lechner F., Sebbel P., Erdmann I., Kundig T. et al: A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 2002; 20: 3104.","journal-title":"Vaccine"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic E.V.","year":"2006","unstructured":"Grgacic E.V. and Anderson D.A.: Virus-like particles: passport to immune recognition. Methods 2006; 40: 60.","journal-title":"Methods"},{"key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/jvi.71.10.7207-7213.1997","article-title":"Expression and self-assembly of empty virus-like particles of hepatitis E virus","volume":"71","author":"Li T.C.","year":"1997","unstructured":"Li T.C., Yamakawa Y., Suzuki K., Tatsumi M., Razak M.A., Uchida T. et al: Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71: 7207.","journal-title":"J Virol"},{"key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang J.","year":"2015","unstructured":"Zhang J., Zhang X.F., Huang S.J., Wu T., Hu Y.M., Wang Z.Z. et al: Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015; 372: 914.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61030-6"},{"key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/erv.09.8","article-title":"Influenza virus-like particle vaccines","volume":"8","author":"Haynes J.R.","year":"2009","unstructured":"Haynes J.R.: Influenza virus-like particle vaccines. Expert Rev Vaccines 2009; 8: 435.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1128\/JVI.75.13.6154-6165.2001","article-title":"Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins","volume":"75","author":"Latham T.","year":"2001","unstructured":"Latham T. and Galarza J.M.: Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 2001; 75: 6154.","journal-title":"J Virol"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2005.18.244"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.043"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.009"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1313186"},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.3390\/v7082821","article-title":"Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB\/C Mice","volume":"7","author":"Zhang L.","year":"2015","unstructured":"Zhang L., Lu J., Chen Y., Shi F., Yu H., Huang C. et al: Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB\/C Mice. Viruses 2015; 7: 4369.","journal-title":"Viruses"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01044-15"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-12-77","article-title":"Pandemic influenza vaccine: characterization of A\/California\/07\/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability","volume":"12","author":"Feshchenko E.","year":"2012","unstructured":"Feshchenko E., Rhodes D.G., Felberbaum R., McPherson C., Rininger J.A., Post P. et al: Pandemic influenza vaccine: characterization of A\/California\/07\/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 2012; 12: 77.","journal-title":"BMC Biotechnol"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615595595"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.13.3"},{"key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.vaccine.2014.01.093","article-title":"Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles","volume":"32","author":"Li T.","year":"2014","unstructured":"Li T., Lin H., Zhang Y., Li M., Wang D., Che Y. et al: Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles. Vaccine 2014; 32: 1921.","journal-title":"Vaccine"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.152"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1073110"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.145"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.11.6527-6532.1992"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.04.078"},{"key":"e_1_3_2_92_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00775-002-0389-4","article-title":"Structural description of the active sites of mouse L-chain ferritin at 1.2 A resolution","volume":"8","author":"Granier T.","year":"2003","unstructured":"Granier T., Langlois d'Estaintot B., Gallois B., Chevalier J.M., Precigoux G., Santambrogio P. et al: Structural description of the active sites of mouse L-chain ferritin at 1.2 A resolution. J Biol Inorg Chem 2003; 8: 105.","journal-title":"J Biol Inorg Chem"},{"key":"e_1_3_2_93_2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/349541a0","article-title":"Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts","volume":"349","author":"Lawson D.M.","year":"1991","unstructured":"Lawson D.M., Artymiuk P.J., Yewdall S.J., Smith J.M., Livingstone J.C., Treffry A. et al: Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 1991; 349: 541.","journal-title":"Nature"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12202"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3927"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.043"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep12501"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012923107"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099881"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234150"},{"key":"e_1_3_2_101_2","article-title":"Flavins and Flavoproteins","author":"Weber SaS S.E.","year":"2014","unstructured":"Weber SaS S.E.: Flavins and Flavoproteins. Methods and Protocols, Series: Methods in Molecular Biology 2014; : 1146.","journal-title":"Methods and Protocols, Series: Methods in Molecular Biology"},{"key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jmb.2006.07.037","article-title":"Multiple assembly states of lumazine synthase: a model relating catalytic function and molecular assembly","volume":"362","author":"Zhang X.","year":"2006","unstructured":"Zhang X., Konarev P.V., Petoukhov M.V., Svergun D.I., Xing L., Cheng R.H. et al: Multiple assembly states of lumazine synthase: a model relating catalytic function and molecular assembly. J Mol Biol 2006; 362: 753.","journal-title":"J Mol Biol"},{"key":"e_1_3_2_103_2","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.75.11.5306","article-title":"Formation of protein micelles from amphiphilic membrane proteins","volume":"75","author":"Simons K.","year":"1978","unstructured":"Simons K., Helenius A., Leonard K., Sarvas M. and Gething M.J.: Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A 1978; 75: 5306.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050852"},{"key":"e_1_3_2_105_2","article-title":"A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age","author":"Glenn G.M.","year":"2015","unstructured":"Glenn G.M., Fries L.F., Thomas D.N., Smith G., Kpamegan E., Lu H. et al: A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age. J Infect Dis 2015; .","journal-title":"J Infect Dis"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.016"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2006.04.007"},{"key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1875933500902010015","article-title":"Design of peptide nanoparticles using simple protein oligomerization domains","volume":"2","author":"Raman S.","year":"2009","unstructured":"Raman S., Machaidze G., Lustig A., Olivieri V., Aebi U. and Burkhard P.: Design of peptide nanoparticles using simple protein oligomerization domains. Open Nanomedicine J 2009; 2: 15.","journal-title":"Open Nanomedicine J"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2008.00746.x"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2012.01423.x"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901957"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(02)00350-0"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.041614998"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1219351"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2011.122"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchem.2107"},{"key":"e_1_3_2_117_2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nnano.2011.127","article-title":"Nanobiotechnology: protein arrays made to order","volume":"6","author":"Yeates T.O.","year":"2011","unstructured":"Yeates T.O.: Nanobiotechnology: protein arrays made to order. Nat Nanotechnol 2011; 6: 541.","journal-title":"Nat Nanotechnol"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1219364"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020450"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.19.10383"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09304"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13404"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381270-4.00019-6"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.48"},{"key":"e_1_3_2_125_2","first-page":"269","article-title":"CYT-006-AngQb, a vaccine against angiotensin II for the potential treatment of hypertension","volume":"10","author":"Phisitkul S.","year":"2009","unstructured":"Phisitkul S.: CYT-006-AngQb, a vaccine against angiotensin II for the potential treatment of hypertension. Curr Opin Investig Drugs 2009; 10: 269.","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/eji.201142361","article-title":"Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients","volume":"42","author":"Goldinger S.M.","year":"2012","unstructured":"Goldinger S.M., Dummer R., Baumgaertner P., Mihic-Probst D., Schwarz K., Hammann-Haenni A. et al: Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients. Eur J Immunol 2012; 42: 3049.","journal-title":"Eur J Immunol"},{"key":"e_1_3_2_127_2","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","article-title":"Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine","volume":"20","author":"Yusibov V.","year":"2002","unstructured":"Yusibov V., Hooper D.C., Spitsin S.V., Fleysh N., Kean R.B., Mikheeva T. et al: Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002; 20: 3155.","journal-title":"Vaccine"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101245"},{"key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.93.11.5335","article-title":"Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice","volume":"93","author":"Mason H.S.","year":"1996","unstructured":"Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K. and Arntzen C.J.: Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A 1996; 93: 5335.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.5.2702-2706.1991"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0666-9"},{"key":"e_1_3_2_132_2","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis F.","year":"2012","unstructured":"De Bernardis F., Amacker M., Arancia S., Sandini S., Gremion C., Zurbriggen R. et al: A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine 2012; 30: 4490.","journal-title":"Vaccine"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055438"},{"key":"e_1_3_2_134_2","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal V a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"Mischler R.","year":"2002","unstructured":"Mischler R. and Metcalfe I.C.: Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 2002; 20: B17.","journal-title":"Vaccine"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.00080.x"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103701530009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103701530009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2015.11.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:44:30Z","timestamp":1778013870000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2015.11.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":134,"alternative-id":["10.1016\/j.csbj.2015.11.001"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2015.11.001","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembling protein nanoparticles in the design of vaccines","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2015.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}